Archives: Speakers

Dr. Leino is the company’s President and Chief Executive Officer and has more than 20 years life science business experience. He is the founder and former President and CEO of BioCis Pharma Ltd as well as the first CEO and COO of Laurantis Pharma Ltd. Previously, Dr. Leino has worked in various R&D management positions in Orion Pharma, BioTie Therapies Ltd, and AstraZeneca in Lund, Sweden. Dr. Leino holds a PhD in biochemistry and has a position as Adjunct Professor in immunology at the University of Turku, Finland.

Dr. Roxana Mittler-Matica is a neurosurgeon with a dual background in medicine and engineering, specializing in spine surgery and the integration of digital health solutions into patient care. She developed digital care pathways and was involved in post-market follow-up studies for medical devices. As an Expert Evaluator for the European Commission, she assessed cutting-edge interdisciplinary research proposals for EU funding, contributing to the advancement of healthcare innovation.

Over the last 7 years I have worked in the Medical Device industry, with a primary focus on clinical operations management. I have accumulated a wealth of international experience, executing trials in all regions of the world; Americas (including US), EMEA and APAC (including China). This has given me many opportunities to manage both internal and external partners, and maintain strong multidiciplinary/multicultural relationships. I have also been fortunate to gain experience with managing all stages of clinical trials, notibly with multiple Early Feasibility, First-in-Human and Pivotal studies in the pre-market space, as well as, a global post-market Registry during my career. To date, most of my experience is rooted in the cardiovascular field, having worked on studies for Cardiac Resynchronization Therapy, Mechanical Circulatory Support, Coronary Arterial Bypass Grafts, and Pumonary Heart Valves. In the past years, I have also branched into other indications, such as Vascular Access Grafts (for hemodialysis) and Peripheral Arterial Grafts in the field of vascular surgery.